Sung Joowhan, Anjum Seher
Internal Medicine, MedStar Southern Maryland Hospital, Clinton, USA.
Translational Mycology, National Institute of Allergy and Infectious Diseases, Bethesda, USA.
Cureus. 2020 Jun 2;12(6):e8408. doi: 10.7759/cureus.8408.
Infection caused by novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has been associated with coagulopathy. We present a case of a previously healthy 49-year-old female who was admitted to the hospital for coronavirus disease 2019 (COVID-19) pneumonia and later found to have extensive deep vein thrombosis (DVT) in all four extremities. This was accompanied by a steep rise in D-dimer levels and positive antiphospholipid antibodies (APLA) on further testing. She clinically improved on hydroxychloroquine and therapeutic anticoagulation. This is one of the first case reports describing APLA-associated DVT in a patient with COVID-19 pneumonia. Transient elevation of APLA from the viral illness may play a role in thrombosis associated with COVID-19.
新型冠状病毒(严重急性呼吸综合征冠状病毒2,SARS-CoV-2)感染与凝血病有关。我们报告一例既往健康的49岁女性,因2019冠状病毒病(COVID-19)肺炎入院,后来发现四肢均有广泛的深静脉血栓形成(DVT)。这伴随着D-二聚体水平的急剧上升以及进一步检测时抗磷脂抗体(APLA)呈阳性。她在接受羟氯喹和治疗性抗凝治疗后临床症状有所改善。这是首批描述COVID-19肺炎患者中APLA相关DVT的病例报告之一。病毒感染导致的APLA短暂升高可能在与COVID-19相关的血栓形成中起作用。